Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Bipolar disorder - Management
QOF indicators

Table 1. Indicators related to bipolar disorder in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract [BMA and NHS Employers, 2009].
Indicator
Points
Payment stages
Records
MH 8
The practice can produce a register of people with schizophrenia, bipolar disorder and other psychoses.
4
Ongoing management
MH 9
The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses with a review recorded in the preceding 15 months. In the review there should be evidence that the patient has been offered routine health promotion and prevention advice appropriate to their age, gender and health status.
23
40–90%
MH 4
The percentage of patients on lithium therapy with a record of serum creatinine and TSH in the preceding 15 months.
1
40–90%
MH 5
The percentage of patients on lithium therapy with a record of lithium levels in the therapeutic range within the previous 6 months.
2
40–90%
MH 6
The percentage of patients on the register who have a comprehensive care plan documented in the records agreed between individuals, their family and/or carers as appropriate.
6
25–50%
MH 7
The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who do not attend the practice for their annual review who are identified and followed up by the practice team within 14 days of non-attendance.
3
40–90%
SMOKING 3
The percentage of patients with any or any combination of the following conditions: coronary heart disease, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who smoke, whose notes record smoking status within the previous 15 months.
30
40–90%
SMOKING 4
The percentage of patients with any or any combination of the following conditions: coronary heart disease, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who smoke, whose notes contain a record that smoking cessation advice or referral to a specialist service, where available, has been offered within the previous 15 months.
30
40–90%

© NHS Institute for Innovation and Improvement